Integrative computational analysis of anti-influenza potential in Caesalpinia mimosoides Lamk hydroethanolic extract
Issued Date
2025-02-01
Resource Type
eISSN
20452322
Scopus ID
2-s2.0-85217731817
Pubmed ID
39893295
Journal Title
Scientific reports
Volume
15
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific reports Vol.15 No.1 (2025) , 3988
Suggested Citation
Klamrak A., Rahman S.S., Nopkuesuk N., Nabnueangsap J., Narkpuk J., Janpan P., Saengkun Y., Soonkum T., Sriburin S., Teeravechyan S., Sitthiwong P., Jangpromma N., Kulchat S., Choowongkomon K., Patramanon R., Chaveerach A., Daduang J., Daduang S. Integrative computational analysis of anti-influenza potential in Caesalpinia mimosoides Lamk hydroethanolic extract. Scientific reports Vol.15 No.1 (2025) , 3988. doi:10.1038/s41598-025-87585-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/105365
Title
Integrative computational analysis of anti-influenza potential in Caesalpinia mimosoides Lamk hydroethanolic extract
Corresponding Author(s)
Other Contributor(s)
Abstract
In a recent study, we used chemical analysis to show that the Caesalpinia mimosoides aqueous extract, which contains a high concentration of simple phenolics, has strong anti-influenza activity. We determined through molecular docking methods that its potential target inhibitor is the neuraminidase. Therefore, our study objectives were to evaluate whether the aqueous-ethanol extract (30% v/v) of this plant species exhibits greater antiviral activity than the aqueous plant extract. The C. mimosoides hydroethanolic extract exhibited potent antioxidant activity in the DPPH assay, with an IC50 value of 15.01 µg/mL, comparable to authentic quercetin (IC50 = 12.72 µg/mL) and approximately 4.91 times greater than standard gallic acid (IC50 = 3.06 µg/mL). Through untargeted metabolomic analyses (UPLC-ESI(±)-QTOF-MS/MS) and subsequent stepwise computational metabolomics analyses, we identified the extract as primarily containing simple phenolics (e.g., gallic acid, ellagic acid, shikimic acid, and chlorogenic acid), flavonoid derivatives (e.g., quercetin, taxifolin, myricitrin, and afzelin), and other bioactive components, including dicarboxylic acids and germacrone. The polyphenol-rich extract showed strong anti-influenza activity, with an IC50 of 2.33 µg/mL against the influenza A/PR/8/34 virus and no cytotoxic effects, as indicated by a CC50 greater than 50 µg/mL. This represents an approximately 3.35-fold increase in effectiveness compared to its corresponding aqueous extract (IC50 = 7.81 µg/mL). Furthermore, the extract demonstrated no hemolytic activity, even at a maximum concentration of 2,000 µg/mL, suggesting its potential as a safe antiviral agent. Molecular docking analyses revealed that the identified phytochemicals can simultaneously interact with the "drug-target binding sites" of neuraminidase (NA) and PB2 subunit of influenza RNA polymerase, indicating their potential polypharmacological effects. The antiviral activity of the ethanolic-aqueous extract against other strains is being explored due to the versatile biological effects of phenolic substances.